ConductScience.org, home

Paper1963289

Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents.

Wolfson JS and 4 others. Antimicrob Agents Chemother, 1990. Cited by 85 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents. Papers, record 1963289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1963289

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
1.95
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wolfson JSJ S
2Hooper DCD C
3McHugh GLG L
4Bozza MAM A
5Swartz MNM N

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Escherichia coliMajor topic
Genes, BacterialMajor topic
QuinolonesMajor topic
Conjugation, Genetic
Microbial Sensitivity Tests
Mutation
beta-Lactams

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI23988NIAID NIH HHSUnited StatesR01AI023988PubMed and NIHNIH RePORTER
R37AI023988NIHNIH RePORTER

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,034,331Recent studies of DNA topoisomerases.Biochim Biophys Acta1987https://conductscience.org/library/papers/3034331PubMed
26,203,890Investigations into the mechanism of action of the antibacterial agent norfloxacin.J Antimicrob Chemother1984https://conductscience.org/library/papers/6203890PubMed
33,056,251Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3056251PubMed
42,404,125DNA breakdown by the 4-quinolones and its significance.J Med Microbiol1990https://conductscience.org/library/papers/2404125PubMed
54,982,198Specific loss of newly replicated deoxyribonucleic acid in nalidixic acid-treated Bacillus subtilis 168.J Bacteriol1969https://conductscience.org/library/papers/4982198PubMed
62,847,641In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/2847641PubMed
74,570,782Bacterial cell division regulation: lysogenization of conditional cell division lon - mutants of Escherichia coli by bacteriophage.J Bacteriol1973https://conductscience.org/library/papers/4570782PubMed
816,559,090Nalidixic Acid and the Metabolism of Escherichia coli.J Bacteriol1970https://conductscience.org/library/papers/16559090PubMed
9319,999Properties of the penicillin-binding proteins of Escherichia coli K12,.Eur J Biochem1977https://conductscience.org/library/papers/319999PubMed
106,343,351Coupling of DNA replication and cell division: sulB is an allele of ftsZ.J Bacteriol1983https://conductscience.org/library/papers/6343351PubMed
116,097,803Biology of bacterial deoxyribonucleic acid topoisomerases.Microbiol Rev1984https://conductscience.org/library/papers/6097803PubMed
122,549,853DNA topoisomerase poisons as antitumor drugs.Annu Rev Biochem1989https://conductscience.org/library/papers/2549853PubMed
13772,446Nalidixic acid and bacterial chromosome replication.Nature1976https://conductscience.org/library/papers/772446PubMed
143,323,160Induction of the SOS response by new 4-quinolones.J Antimicrob Chemother1987https://conductscience.org/library/papers/3323160PubMed
153,546,699The response of Escherichia coli to ciprofloxacin and norfloxacin.J Med Microbiol1987https://conductscience.org/library/papers/3546699PubMed
163,852,657Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3852657PubMed
174,867,214Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli.J Bacteriol1968https://conductscience.org/library/papers/4867214PubMed
1814,219,026MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.J Bacteriol1964https://conductscience.org/library/papers/14219026PubMed
1957,241DNA synthesis inhibition and the induction of protein X in Escherichia coli.J Mol Biol1976https://conductscience.org/library/papers/57241PubMed
206,363,389Use of phi(glp-lac) in studies of respiratory regulation of the Escherichia coli anaerobic sn-glycerol-3-phosphate dehydrogenase genes (glpAB).J Bacteriol1984https://conductscience.org/library/papers/6363389PubMed

See all 52 references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
42,875,544Bacterial strategies for surviving antibiotics during urinary tract infection: could uropathogenic Escherichia coli be persisters?Nat Rev Urol2026https://conductscience.org/library/papers/42875544PubMed
42,371,925An integrative multi-omics approach points to membrane composition as a key factor in E. coli persistence.PLoS One2026https://conductscience.org/library/papers/42371925PubMed
41,481,724Differentiation between regulated and disrupted growth arrests allows tailoring of effective treatments for antibiotic persistence.Sci Adv2026https://conductscience.org/library/papers/41481724PubMed
40,723,930Effect of Pefloxacin on Clostridioides difficile R20291 Persister Cells Formation.Antibiotics (Basel)2025https://conductscience.org/library/papers/40723930PubMed
40,426,573Surviving Colonies of Pseudomonas aeruginosa Isolated In Vivo from Infected, Antibiotic-Treated Galleria mellonella Larvae Acquire an Antibiotic-Tolerant Phenotype.Antibiotics (Basel)2025https://conductscience.org/library/papers/40426573PubMed
37,415,820Dysregulated NAD(H) homeostasis associated with ciprofloxacin tolerance in Escherichia coli investigated on a single-cell level with the Peredox [NADH:NAD+] biosensor.Front Microbiol2023https://conductscience.org/library/papers/37415820PubMed
36,350,213Assessing the relative importance of bacterial resistance, persistence and hyper-mutation for antibiotic treatment failure.Proc Biol Sci2022https://conductscience.org/library/papers/36350213PubMed
35,451,002Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study.Clin Infect Dis2022https://conductscience.org/library/papers/35451002PubMed
35,164,563Interaction Tolerance Detection Test for Understanding the Killing Efficacy of Directional Antibiotic Combinations.mBio2021https://conductscience.org/library/papers/35164563PubMed
34,787,710Awakening sleeper cells: a narrative review on bacterial magic spot synthetases as potential drug targets to overcome persistence.Curr Genet2022https://conductscience.org/library/papers/34787710PubMed
34,446,803Multilocus sequence analysis reveals genetic diversity in Staphylococcus aureus isolate of goat with mastitis persistent after treatment with enrofloxacin.Sci Rep2021https://conductscience.org/library/papers/34446803PubMed
34,355,746Phenotypic heterogeneity in persisters: a novel 'hunker' theory of persistence.FEMS Microbiol Rev2022https://conductscience.org/library/papers/34355746PubMed
34,208,120Biological Functions of Type II Toxin-Antitoxin Systems in Bacteria.Microorganisms2021https://conductscience.org/library/papers/34208120PubMed
33,400,359Antibiotic resistance and persistence-Implications for human health and treatment perspectives.EMBO Rep2020https://conductscience.org/library/papers/33400359PubMed
33,177,189In Vitro Studies of Persister Cells.Microbiol Mol Biol Rev2020https://conductscience.org/library/papers/33177189PubMed
32,823,501A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery.Antibiotics (Basel)2020https://conductscience.org/library/papers/32823501PubMed
32,461,608Evolutionary causes and consequences of bacterial antibiotic persistence.Nat Rev Microbiol2020https://conductscience.org/library/papers/32461608PubMed
32,029,596Loss of phenotypic inheritance associated with ydcI mutation leads to increased frequency of small, slow persisters in Escherichia coli.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32029596PubMed
31,686,867The role of cfa gene in ampicillin tolerance in Shigella.Infect Drug Resist2019https://conductscience.org/library/papers/31686867PubMed
31,463,787Bacterial persistence: Fundamentals and clinical importance.J Microbiol2019https://conductscience.org/library/papers/31463787PubMed

See all 57 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1963289

GET https://conductscience.org/api/papers/v1/1963289/references?page=2